Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect
Dendritic cells (DCs) are immune specialized cells playing a critical role in promoting immune response against antigens, and may represent important targets for therapeutic interventions in cancer. DCs can be stimulated ex vivo with pro-inflammatory molecules and loaded with tumor-specific antigen(...
Enregistré dans:
Auteurs principaux: | Sara Nava, Daniela Lisini, Simona Frigerio, Anna Bersano |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/49f7a6990a9644eca8b165bba329a7dd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
par: Elena V. Abakushina, et autres
Publié: (2021) -
Toll-like receptor 3-induced immune response by poly(D,L-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy
par: Han HD, et autres
Publié: (2016) -
TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
par: Salazar-Onfray,Flavio, et autres
Publié: (2013) -
EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
par: V. V. Kurilin, et autres
Publié: (2021) -
Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
par: Yinyan Yin, et autres
Publié: (2021)